Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. [electronic resource]
Producer: 20030814Description: 2664-72 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Glomerular Filtration Rate -- drug effects
- Humans
- Infusions, Intravenous
- Kidney Diseases -- physiopathology
- Kidney Function Tests
- Male
- Maximum Tolerated Dose
- Middle Aged
- National Institutes of Health (U.S.)
- Neoplasm Staging
- Neoplasms -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Probability
- Reference Values
- Risk Assessment
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.